MONODES(N-CARBOXYMETHYL)VALINE DACLATASVIR HYDROCHLORIDE

UNII:	VV5GL9HF45
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₃H₃₉N₇O₃.₃ClH
Preferred Substance Name:	MONODES(N-CARBOXYMETHYL)VALINE DACLATASVIR HYDROCHLORIDE
InChIKey:	IKMPDBICSMYUEC-MXFGYMLFSA-N
GSRS Full Record:	VV5GL9HF45 i

1258311-20-4
Carbamic acid, N-[(1S)-2-methyl-1-[[(2S)-2-[5-[4′-[2-(2S)-2-pyrrolidinyl-1H-imidazol-5-yl][1,1′-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]-, methyl ester, hydrochloride (1:3)
Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-(4'-{2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl}-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate trihydrochloride
Monodes(N-carboxymethyl)valine Daclatasvir Hydrochloride

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MONODES(N-CARBOXYMETHYL)VALINE DACLATASVIR HYDROCHLORIDE

Synonyms and Mappings

Resources